InvestorsHub Logo

Kpauliukonis

01/13/20 1:42 PM

#27628 RE: samlion1 #27627

We believe the potential for Multikine to achieve better survival outcomes remains underappreciated."

There’s an understatement!

drkazmd65

01/13/20 3:07 PM

#27638 RE: samlion1 #27627

If Multikine is actually useful,... then $18 is a seriously low-ball endpoint. But still nice to see at least some recognition and response.